CASI logo

CASI Pharmaceuticals (CASI)

Profile

Full Name

CASI Pharmaceuticals, Inc.

Ticker Symbol

CASI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

China

IPO

June 12, 1996

Indexes

Not included

Website

http://www.casipharmaceuticals.com

Employees

233

Key Details

Price

$1.99(-5.24%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$28.54M(-15.77% YoY)

Annual EPS

-$2.56(-26.73% YoY)

PE ratio

-

Next earnings date

May 20, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.99
CASI price is $1.99

30-Day Relative Volume

0.43
CASI 30-day relative volume is 0.43

Price Performance

Price Most recent change

-5.24%
CASI price was down -5.24% on Apr 15, 2025

Price YTD change

-29.68%
CASI price is down -29.68% since January 1st

Price 1-year change

-20.4%
CASI price is down -20.4% year-on-year

Price 3-year change

-67.9%
CASI price is down -67.9% over the past 3 years

Price Range

Price All-time high

$11137.50
CASI price is currently -99.98% below its historical high of $11137.50

Price 3-year low

$1.45
CASI price is currently +37.24% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$30.83M
CASI market capitalization is $30.83 million

Market cap 3-year change

-63.45%
CASI market capitalization is down -63.45% over the past 3 years

Market cap All-time high

$1.42B
CASI market capitalization is currently -97.84% below its historical high of $1.42 billion

Market cap sector rank

31.99%
CASI market capitalization is higher than 31.99% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+15.61%
CASI shares outstanding is up +15.61% year-on-year

Shares Outstanding 3-Year Change

+13.87%
CASI shares outstanding is up +13.87% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.63
CASI beta is 0.63

200-day SMA

$4.46
CASI price is currently -55.39% below its 200-day simple moving average

50-day SMA

$2.27
CASI price is currently -12.50% below its 50-day simple moving average

RSI

44.06
CASI 14-day relative strength index is 44.06

Volume

0.43
CASI 30-day relative volume is 0.43

ATR

$0.21
CASI average true range is $0.21

10-day Historical Volatility

74.36%
CASI 10-day historical volatility is 74.36%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$28.54M
CASI annual revenue is $28.54 million

Revenue Analysts estimate

$18.82M
CASI annual revenue is currently +51.66% higher than the consensus analysts' forecast

Revenue 1-year change

-15.77%
CASI annual revenue is down -15.77% year-on-year

Revenue Sector rank

38.55%
CASI annual revenue is higher than 38.55% of companies in Healthcare sector

EPS

EPS

-$2.56
CASI annual earnings per share is -$2.56

EPS Analysts estimate

-
CASI annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-26.73%
CASI annual earnings per share is down -26.73% year-on-year

EPS Sector rank

33.72%
CASI annual earnings per share is higher than 33.72% of companies in Healthcare sector

Profit

Gross profit

$11.15M
CASI annual gross profit is $11.15 million

Gross margin

39.06%
CASI annual gross profit margin is 39.06%

Operating profit

-$39.21M
CASI annual operating income is -$39.21 million

Operating margin

-137.41%
CASI annual operating profit margin is -137.41%

Net income

-$39.26M
CASI annual net profit is -$39.26 million

Net margin

-137.57%
CASI annual net profit margin is -137.57%

Expenses

Total expenses

$67.75M
CASI annual total expenses is $67.75 million

Operating expenses

$50.36M
CASI annual total operating expenses is $50.36 million

Cost of goods sold

$17.39M
CASI annual cost of goods sold is $17.39 million

Selling, general & administrative expenses

$41.44M
CASI annual SGA is $41.44 million

Depreciation and amortization

$2.33M
CASI annual depreciation & amortization is $2.33 million

Interest expense

$871.00K
CASI annual interest expense is $871.00 thousand

Income tax

$0.00
CASI annual income tax is $0.00

EBIT & EBITDA

EBIT

-$37.20M
CASI annual earnings before interest & taxes is -$37.20 million

EBITDA

-$34.87M
CASI annual EBITDA is -$34.87 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$53.67M
CASI annual total assets is $53.67 million

Non current assets

$13.90M
CASI annual long term assets is $13.90 million

Current assets

$39.58M
CASI annual total current assets is $39.58 million

Cash and cash equivalents

$13.47M
CASI annual cash & cash equivalents is $13.47 million

Accounts receivable

$15.35M
CASI annual accounts receivable is $15.35 million

Inventory

$5.25M
CASI annual inventory is $5.25 million

Liabilities

Total liabilities

$51.82M
CASI annual total liabilities is $51.82 million

Long term liabilities

$15.37M
CASI annual total long term liabilities is $15.37 million

Current liabilities

$36.45M
CASI annual total current liabilities is $36.45 million

Accounts payable

$2.72M
CASI annual accounts payable is $2.72 million

Debt

Total debt

$22.14M
CASI annual total debt is $22.14 million

Total debt 1-year change

+4.25%
CASI annual total debt is up +4.25% year-on-year

Long term debt

$2.54M
CASI annual long term debt is $2.54 million

Short term debt

$19.61M
CASI annual short term debt is $19.61 million

Equity & Capital

Shareholders equity

$1.85M
CASI annual stockholders equity is $1.85 million

Book value

$1.85M
CASI annual book value is $1.85 million

Retained earnings

-$700.08M
CASI annual retained earnings is -$700.08 million

Working capital

$3.12M
CASI annual working capital is $3.12 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$29.22M
CASI annual cash flow from operations is -$29.22 million

Cash from operations 1-year change

-46.36%
CASI annual cash flow from operations is down -46.36% year-on-year

Cash from investing

$11.24M
CASI annual cash flow from investing activities is $11.24 million

Cash from investing 1-year change

+216.24%
CASI annual cash flow from investing activities is up +216.24% year-on-year

Cash from financing

$15.43M
CASI annual cash flow from financing activities is $15.43 million

Cash from financing 1-year change

+1801.65%
CASI annual cash flow from financing activities is up +1801.65% year-on-year

CAPEX

CAPEX

$240.00K
CASI annual capital expenditures is $240.00 thousand

CAPEX 1-year change

-89.29%
CASI annual capital expenditures is down -89.29% year-on-year

Free Cash Flow

Free cash flow

-$29.46M
CASI annual free cash flow is -$29.46 million

Free cash flow 1-year change

-32.67%
CASI annual free cash flow is down -32.67% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

39.06%
CASI annual gross profit margin is 39.06%

Operating margin

-137.41%
CASI annual operating profit margin is -137.41%

Net margin

-137.57%
CASI annual net profit margin is -137.57%

ROA & ROE

ROA

-60.89%
CASI annual return on assets is -60.89%

ROE

-301.80%
CASI annual return on equity is -301.80%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CASI price to earnings ratio value is unknown

PE ratio Sector rank

-
CASI price to earnings ratio is unknown

PB Ratio

PB ratio

16.66
CASI price to book ratio is 16.66

PB ratio Sector rank

96.13%
CASI price to book ratio is higher than 96.13% of companies in Healthcare sector

PS Ratio

PS ratio

1.08
CASI price to sales ratio is 1.08

PS ratio Sector rank

28.85%
CASI price to sales ratio is higher than 28.85% of companies in Healthcare sector

Enterprise value

Enterprise value

$39.50M
CASI enterprise value is $39.50 million

Enterprise value Sector rank

38.76%
CASI enterprise value is higher than 38.76% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.06
CASI EV/EBITDA is -1.06

EV/EBITDA Sector rank

42.17%
CASI EV/EBITDA is higher than 42.17% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.09
CASI annual current ratio is 1.09

Quick ratio

0.94
CASI annual quick ratio is 0.94

Leverage

Debt to equity

9.93
CASI annual debt to equity ratio is 9.93

Interest coverage ratio

-42.71
CASI annual interest coverage ratio is -42.71

Risk & Stability

Piotroski F-Score

-
CASI piotroski f-score value is unknown

Altman Z-Score

-19.59
CASI altman z-score is -19.59

Analyst ratings

Recent major analysts updates

Apr 9, 25 HC Wainwright & Co.
Buy
May 15, 24 HC Wainwright & Co.
Buy
Nov 15, 23 HC Wainwright & Co.
Buy
Aug 14, 23 HC Wainwright & Co.
Buy
May 22, 23 HC Wainwright & Co.
Buy
Nov 16, 22 BTIG
Buy
Nov 15, 22 HC Wainwright & Co.
Buy
Aug 15, 22 HC Wainwright & Co.
Buy
Jun 3, 22 BTIG
Buy
May 16, 22 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

ESLA logo
Estrella Immunopharma (ESLA)
INKT logo
MiNK Therapeutics (INKT)
Cadrenal Therapeutics (CVKD)
FEMY logo
Femasys (FEMY)
OS Therapies Incorporated (OSTX)
Spectral AI (MDAI)
LSB logo
LakeShore Biopharma Co Ltd (LSB)
BNR logo
Burning Rock Biotech Limited (BNR)
BOLD logo
Boundless Bio (BOLD)
  • What is the ticker symbol for CASI Pharmaceuticals?
  • Does CASI Pharmaceuticals pay dividends?
  • What sector is CASI Pharmaceuticals in?
  • What industry is CASI Pharmaceuticals in?
  • What country is CASI Pharmaceuticals based in?
  • When did CASI Pharmaceuticals go public?
  • Is CASI Pharmaceuticals in the S&P 500?
  • Is CASI Pharmaceuticals in the NASDAQ 100?
  • Is CASI Pharmaceuticals in the Dow Jones?
  • When was CASI Pharmaceuticals's last earnings report?
  • When does CASI Pharmaceuticals report earnings?
  • Should I buy CASI Pharmaceuticals stock now?

What is the ticker symbol for CASI Pharmaceuticals?

The ticker symbol for CASI Pharmaceuticals is NASDAQ:CASI

Does CASI Pharmaceuticals pay dividends?

No, CASI Pharmaceuticals does not pay dividends

What sector is CASI Pharmaceuticals in?

CASI Pharmaceuticals is in the Healthcare sector

What industry is CASI Pharmaceuticals in?

CASI Pharmaceuticals is in the Biotechnology industry

What country is CASI Pharmaceuticals based in?

CASI Pharmaceuticals is headquartered in China

When did CASI Pharmaceuticals go public?

CASI Pharmaceuticals's initial public offering (IPO) was on June 12, 1996

Is CASI Pharmaceuticals in the S&P 500?

No, CASI Pharmaceuticals is not included in the S&P 500 index

Is CASI Pharmaceuticals in the NASDAQ 100?

No, CASI Pharmaceuticals is not included in the NASDAQ 100 index

Is CASI Pharmaceuticals in the Dow Jones?

No, CASI Pharmaceuticals is not included in the Dow Jones index

When was CASI Pharmaceuticals's last earnings report?

CASI Pharmaceuticals's most recent earnings report was on Mar 31, 2025

When does CASI Pharmaceuticals report earnings?

The next expected earnings date for CASI Pharmaceuticals is May 20, 2025

Should I buy CASI Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page